Table 5.
The number of trials (n = 113) grouped by and across reporting of the economic/financial assessment methodology, type of economic assessment, and if the economic/financial difference between treatments was evaluated with a statistical model by whether the economic/financial outcomes were reported or not as an outcome of interest
Methodology reported (n = 83)1 | Methodology not reported (n = 30)1 | Total | |||||||
---|---|---|---|---|---|---|---|---|---|
Economic/financial outcome stated as an outcome of interest | Economic assessment reported (n = 29)2 | Economic assessment not reported (n = 54)2 | Economic assessment reported (n = 21)2 | Economic assessment not reported (n = 9)2 | |||||
Statistically evaluated3 | Not statistically evaluated3 | Statistically evaluated3 | Not statistically evaluated3 | Statistically evaluated3 | Not statistically evaluated3 | Statistically evaluated3 | Not statistically evaluated3 | ||
Yes | 9 | 14 | 26 | 17 | 0 | 16 | 2 | 7 | 91 |
No | 1 | 5 | 7 | 4 | 5 | 0 | 0 | 0 | 22 |
Total | 10 | 19 | 33 | 21 | 5 | 16 | 2 | 7 |
If the methodology used for the economic/financial assessment was reported for the trial.
If the type of economic assessment was reported.
Whether the economic/financial difference between treatment was evaluated using a statistical model.